Vendor Intelligence Report: Expert Peptide

Published 3 Jul 2026. 24-page investigative report on who is behind Expert Peptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Expert Peptide's Finnrick record is favorable, but extremely narrow. Across 1 Finnrick lab test, Expert Peptide has 1 pass / 0 fail — an overall pass rate of 100%. The single result is for Retatrutide, giving Retatrutide buyers an encouraging first datapoint; it does not establish lot-to-lot consistency or support confidence across the broader catalog.

The sharper diligence issue is COA provenance. The homepage claims independent third-party COAs, while the BPC-157 and Retatrutide certificate details reviewed in the report use internal QMS and in-house specification language rather than a named outside laboratory. That does not erase the Retatrutide pass, but it changes how much trust buyers should place in vendor-supplied certificates.

Accountability signals are also thin. The site gives first-name WhatsApp and email contacts, but no disclosed legal entity, operating address, leadership, privacy policy, or terms page was verified in the field capture. Registrar, email, media, and COA-signoff artifacts point toward a China-linked operation despite Hong Kong and U.S. phone routing.

The web footprint adds friction rather than reassurance: live template/demo corporate pages, a WordPress author archive exposing a sales-contact email, RUO language paired with consumer health claims, and a near-identical plural-domain ecosystem whose reviews and coupon trail should not be imported to this singular site. Expert Peptide is not an automatic reject on Retatrutide, but batch verification and counterparty identification matter before payment.

Inside the full report:

  • Appendix A laboratory data and methodology-divergence charts for the one tested product
  • COA provenance comparison across the homepage claim and BPC-157/Retatrutide certificate language
  • Corporate-accountability review of contacts, missing legal pages, WHOIS, DNS, and email infrastructure
  • WordPress and Wayback timeline analysis covering older artifacts, rebuild signals, and archive gaps
  • Brand-confusion and coupon-channel analysis separating expertpeptide.com from expertpeptides.com
  • RUO/marketing review of AOD9604 and the material buyer-risk matrix

Risk assessment

  • COA misrepresentation and batch-verification risk — high: The homepage says all COAs are issued by independent third-party laboratories, but BPC-157 and Retatrutide COAs use in-house QMS/specification language and no named independent lab.
  • Corporate accountability and jurisdiction-opacity risk — high: No legal entity, physical address, executives, privacy policy, or terms were found; HK/US contact numbers sit alongside Alibaba/WeChat/Chinese-lab indicators and no exact HK entity match.
  • Non-Retatrutide product testing-coverage risk — medium: Finnrick has 1 total test, 1 pass / 0 fail, only for Retatrutide at 80.39%; all other products lack Finnrick coverage in the supplied record.
  • Website governance and misleading-template-content risk — medium: Live WordPress pages expose 2018 demo posts and fake Investor Relations/Sustainability boilerplate, weakening confidence in the vendor's controls and history signals.
  • RUO contradiction and medical-claim risk — medium: The AOD9604 page pairs RUO language with consumer claims such as weight-loss treatment and osteoarthritis/cholesterol benefits, increasing regulatory and marketing-integrity risk.
  • Brand-confusion and unofficial coupon-channel risk — medium: expertpeptide.com collides with the separate older expertpeptides.com ecosystem; no authorized-channel/reseller list, batch lookup, or anti-counterfeit guidance resolves the confusion.